Concepedia

Kiran K. Rajasenan

KK

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2007

Affiliations

University of Pittsburgh(Current)

Kiran K. Rajasenan is an author at University of Pittsburgh specializing in medicine, phase ii investigation, and chemotherapy.

Publications per year

2007–2016

4

Publications

4

Phase II trial of pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): An interim analysis

M. V. Karamouzis, David Friedland, R. R. Johnson et al. · Journal of Clinical Oncology · 2007 · 20 citations

Medicine, Oncology, Pharmacology +15

A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas

Shelly S. Lo, Alok A. Khorana, Milind Javle et al. · Oncology · 2010 · 19 citations

Medicine, Oncology, Pharmacology +14

Biosimilars: Opportunities to Promote Optimization Through Payer and Provider Collaboration

Chronis Manolis, Kiran K. Rajasenan, William Harwin et al. · Journal of Managed Care & Specialty Pharmacy · 2016 · 17 citations · Full text

Public Affairs, Health Policy, Health Services Administration +17

Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial

Trevor Feinstein, L. E. Raez, Kiran K. Rajasenan et al. · Journal of Clinical Oncology · 2008 · 14 citations

Medicine, Oncology, Pharmacology +15

1–4 of 4